DBV Technologies liquidity contract report
Analysis based on 6 articles · First reported Jul 06, 2026 · Last updated Jul 06, 2026
This routine regulatory filing has minimal market impact. It provides transparency on DBV Technologies' liquidity management but does not indicate any material change in the company's financial health or operations.
DBV Technologies, a late-stage biopharmaceutical company, issued its half-year report on the liquidity contract with Oddo BHF for the period from January 1 to June 30, 2026. The report details the assets in the liquidity account as of June 30, 2026: 146,321 shares and €396,088.22. During the period, 1,989 buy transactions and 2,012 sales transactions were executed, with total purchase volume of 2,707,915 shares (€8,836,273.65) and sales volume of 2,636,174 shares (€8,704,457.81). The contract is implemented in accordance with AMF Decision No. 2021-01.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard